Biocon's target factory. #SouthKorea's 8-year effort to create an integrated platform for novel target and lead development provides an academic #drugdiscovery model for other emerging economies https://go.nature.com/2Dsg36O #bioentrepreneur pic.twitter.com/DHgwaUO3ZC